Neurobiological Technologies(OTC) NTII

Neurobiological Technologies, Inc. is a biotechnology company that has shifted its focus towards liquidation and dissolution, a plan endorsed by stockholders in 2009. Established in 1987, the company was previously dedicated to developing experimental pharmaceutical treatments for various human ailments.

Products and Services

• Formerly focused on experimental pharmaceutical treatments
• Engaged in research and development in the biotechnology sector
• Currently in the process of liquidation

Growth Outlook

• Liquidation plan endorsed by stockholders indicates a strategic exit
• Company's historical focus on biotechnology may attract future interest
• Potential for asset recovery as liquidation progresses

Financial Highlights

• Recent quarterly revenue of 6,026,000 demonstrates past operational success
• Cash and short-term investments totaled 26,489,000 as of September 2009
• Net income of 5,405,000 in the latest quarter reflects historical profitability

Neurobiological Technologies, Inc. has a rich history in the biotechnology sector, although it is currently navigating a significant transition towards liquidation. The company's past focus on developing pharmaceutical treatments has positioned it within a sector that remains attractive to investors. The recent financial data indicates a history of revenue generation and cash reserves, which may provide a foundation for potential asset recovery during the liquidation process. As the company moves forward, the strategic decisions made during this transition will be critical in determining the ultimate outcomes for stakeholders.